Standard BioTools Inc (NASDAQ: LAB) open the trading on Thursday, with a bit cautious approach as it glided -7.86% to $1.29, before settling in for the price of $1.4 at the close. Taking a more long-term approach, LAB posted a 52-week range of $0.92-$2.32.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 11.61%. Meanwhile, its Annual Earning per share during the time was 11.61%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 66.03%. This publicly-traded company’s shares outstanding now amounts to $381.69 million, simultaneously with a float of $365.52 million. The organization now has a market capitalization sitting at $492.77 million. At the time of writing, stock’s 50-day Moving Average stood at $1.3027, while the 200-day Moving Average is $1.2803.
Standard BioTools Inc (LAB) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Medical Devices industry. Standard BioTools Inc’s current insider ownership accounts for 4.31%, in contrast to 74.16% institutional ownership. According to the most recent insider trade that took place on Sep 09 ’25, this organization’s Director bought 100,000 shares at the rate of 1.29, making the entire transaction reach 128,920 in total value, affecting insider ownership by 60,875,000. Preceding that transaction, on Sep 04 ’25, Company’s Director bought 250,000 for 1.28, making the whole transaction’s value amount to 319,350. This particular insider is now the holder of 60,775,000 in total.
Standard BioTools Inc (LAB) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.02 per share during the current fiscal year.
Standard BioTools Inc’s EPS increase for this current 12-month fiscal period is 66.03% and is forecasted to reach -0.15 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 39.44% through the next 5 years, which can be compared against the 11.61% growth it accomplished over the previous five years trading on the market.
Standard BioTools Inc (NASDAQ: LAB) Trading Performance Indicators
Let’s observe the current performance indicators for Standard BioTools Inc (LAB). It’s Quick Ratio in the last reported quarter now stands at 4.92. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 3.19.
In the same vein, LAB’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.32, a figure that is expected to reach -0.04 in the next quarter, and analysts are predicting that it will be -0.15 at the market close of one year from today.
Technical Analysis of Standard BioTools Inc (LAB)
[Standard BioTools Inc, LAB] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 37.12% While, its Average True Range was 46.02.
Raw Stochastic average of Standard BioTools Inc (LAB) in the period of the previous 100 days is set at 55.12%, which indicates a major rise in contrast to 20.00% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.0811 that was higher than 0.0801 volatility it exhibited in the past 100-days period.
